Cargando…

HbA(1c) as a Predictor of Diabetes and as an Outcome in the Diabetes Prevention Program: A Randomized Clinical Trial

OBJECTIVE: Glycated hemoglobin (HbA(1c)), a standard measure of chronic glycemia for managing diabetes, has been proposed to diagnose diabetes and identify people at risk. The Diabetes Prevention Program (DPP) was a 3.2-year randomized clinical trial of preventing type 2 diabetes with a 10-year foll...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2015
Materias:	Epidemiology/Health Services Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274777/ https://www.ncbi.nlm.nih.gov/pubmed/25336746 http://dx.doi.org/10.2337/dc14-0886

Ejemplares similares

HbA(1c) and Coronary Heart Disease Risk Among Diabetic Patients
por: Zhao, Wenhui, et al.
Publicado: (2014)

Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospective observational study
por: Skriver, Mette V, et al.
Publicado: (2015)

The Impact of Carbamylation and Anemia on HbA(1c)’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease
por: Tang, Mengyao, et al.
Publicado: (2023)

Sleep characteristics and HbA1c in patients with type 2 diabetes on glucose-lowering medication
por: Tan, Xiao, et al.
Publicado: (2020)

Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study
por: Barron, Emma, et al.
Publicado: (2020)

Undiagnosed diabetes based on HbA(1c) by socioeconomic status and healthcare consumption in the Tromsø Study 1994–2016
por: Ruiz, Paz Lopez-Doriga, et al.
Publicado: (2021)

Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset
por: Edqvist, Jon, et al.
Publicado: (2021)

Development of a 5-year risk prediction model for type 2 diabetes in individuals with incident HbA1c-defined pre-diabetes in Denmark
por: Nicolaisen, Sia K, et al.
Publicado: (2022)

Derivation and external validation of a clinical version of the German Diabetes Risk Score (GDRS) including measures of HbA1c
por: Mühlenbruch, Kristin, et al.
Publicado: (2018)

Empirically Establishing Blood Glucose Targets to Achieve HbA(1c) Goals
por: Wei, Nancy, et al.
Publicado: (2014)

Assessment of diabetes and prediabetes prevalence and predictors by HbA1c in a population from sub-Saharan Africa with a high proportion of anemia: a prospective cross-sectional study
por: Hodel, Nikolai Carl, et al.
Publicado: (2020)

Does cancer risk increase with HbA(1c), independent of diabetes?
por: de Beer, J C, et al.
Publicado: (2014)

Medical expenditure trajectory and HbA1c progression prior to and after clinical diagnosis of type 2 diabetes in a commercially insured population in the USA
por: Pagán, Lorissa, et al.
Publicado: (2023)

Glycated hemoglobin (HbA1c) as diagnostic criteria for diabetes: the optimal cut-off points values for the Pakistani population; a study from second National Diabetes Survey of Pakistan (NDSP) 2016–2017
por: Basit, Abdul, et al.
Publicado: (2020)

New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer
por: Lu, Yunxia, et al.
Publicado: (2015)

Effect of the interaction between physical activity and estimated macronutrient intake on HbA1c: population-based cross-sectional and longitudinal studies
por: Furukawa, Takuma, et al.
Publicado: (2022)

Long-term Outcomes of Lifestyle Intervention to Prevent Diabetes in American Indian and Alaska Native Communities: The Special Diabetes Program for Indians Diabetes Prevention Program
por: Jiang, Luohua, et al.
Publicado: (2018)

Associations between adolescent experiences, parent experiences and HbA1c: results following two surveys based on the Norwegian Childhood Diabetes Registry (NCDR)
por: Iversen, Hilde Hestad, et al.
Publicado: (2019)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Type 2 diabetes medication and HbA1c levels in North Karelia Finland, 2013–2019
por: Wikström, Katja, et al.
Publicado: (2022)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC’s National Diabetes Prevention Program
por: Ely, Elizabeth K., et al.
Publicado: (2017)

The Stepwise Approach to Diabetes Prevention: Results From the D-CLIP Randomized Controlled Trial
por: Weber, Mary Beth, et al.
Publicado: (2016)

Assessing widening disparities in HbA1c and systolic blood pressure retesting during the COVID-19 pandemic in an LGBTQ+-focused federally qualified health center in Chicago: a retrospective cohort study using electronic health records
por: Rivera, Adovich S, et al.
Publicado: (2022)

Use of metformin following a population-level intervention to encourage people with pre-diabetes to enroll in the National Diabetes Prevention Program
por: Hurst, Thomas E, et al.
Publicado: (2021)

HbA1c – A predictor of dyslipidemia in type 2 Diabetes Mellitus
por: Kidwai, Saera Suhail, et al.
Publicado: (2020)

HbA1c as a predictor for response of bevacizumab in diabetic macular oedema
por: Sharma, Sadhana, et al.
Publicado: (2020)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Is HbA1c an Accurate Predictor for Diabetes Risk in Patients with Chronic Periodontitis?
por: ANSARI MOGHADAM, Somayeh, et al.
Publicado: (2014)

Predictive utilities of lipid traits, lipoprotein subfractions and other risk factors for incident diabetes: a machine learning approach in the Diabetes Prevention Program
por: Varga, Tibor V, et al.
Publicado: (2021)

Trends in known and undiagnosed diabetes, HbA1c levels, cardiometabolic risk factors and diabetes treatment target achievement in repeated cross-sectional surveys: the population-based Tromsø Study 1994–2016
por: Langholz, Petja Lyn, et al.
Publicado: (2021)

Lifestyle and Metformin Interventions Have a Durable Effect to Lower CRP and tPA Levels in the Diabetes Prevention Program Except in Those Who Develop Diabetes
por: Goldberg, Ronald B., et al.
Publicado: (2014)

A Randomized Trial of a Home System to Reduce Nocturnal Hypoglycemia in Type 1 Diabetes
por: Maahs, David M., et al.
Publicado: (2014)

IDF2022-0948 Health Inequality and its link to HbA1c Test Recovery in a Developed Health Economy: In a ‘Nearly Post COVID-19’ World
por: Fryer, A., et al.
Publicado: (2023)

Challenges of diabetes prevention in the real world: results and lessons from the Melbourne Diabetes Prevention Study
por: Dunbar, James A, et al.
Publicado: (2015)

Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes
por: Sosenko, Jay M., et al.
Publicado: (2014)

Preventing diabetes after pregnancy with gestational diabetes in a Cree community: an inductive thematic analysis
por: Pace, Romina, et al.
Publicado: (2020)

Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes
por: Harman, Nicola L, et al.
Publicado: (2019)

Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials
por: Nathan, Brandon M., et al.
Publicado: (2017)

The Utility of HbA1c as a Diagnostic Criterion of Diabetes
por: Kim, Hee-Jung, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_q6d2nv9sglvh4ddir0gfk3cvho